GI tumor cells commonly resist ferroptosis inducers (e.g., erastin, RSL3) and certain chemotherapeutics by upregulating glutathione peroxidase 4 (GPX4), thereby enhancing antioxidant capacity (72–74). The gene discussed is GPX4; the disease is digestive system neoplasm.